Patent: 5,716,830
✉ Email this page to a colleague
Summary for Patent: 5,716,830
| Title: | Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus |
| Abstract: | Immortalized non-tumorigenic or tumorigenic human prostatic epithelial and fibroblast cell lines and derivatives thereof, containing DNA of a hybrid virus between adenovirus 12 and simian virus 40. The cell lines are useful for research on causes, treatment and prevention of prostate cancer, benign prostatic hyperplasia, male infertility, birth defects, aging and assessment of environmental toxic agents. |
| Inventor(s): | Webber; Mukta M. (Eagle, MI), Rhim; Johng S. (Potomac, MD) |
| Assignee: | Board of Trustees operating Michigan State University (East Lansing, MI) The United States of America as represented by the Department of Health (Washington, DC) |
| Application Number: | 08/805,596 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,716,830
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2014-04-28 |
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2014-04-28 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
